Form 4 for EYPT EyePoint, Inc.
Accepted 2023-02-13 00:00:00 ET · period of report 2023-02-09 · accession 0001562180-23-001330 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-02-13 | 2023-02-09 | EYPT | Lurker Nancy | CEO, Dir | M - OptEx | $0.00 | +37.5K | 170.6K | +28% | $0 |
| DM | 2023-02-13 | 2023-02-09 | EYPT | Lurker Nancy | CEO, Dir | M - OptEx | $0.00 | -37.5K | 17.5K | -68% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-02-09 | M | A | 20,000 | $0.00 | 190,559 | D | — | — | |
| 2 | Common | Common Stock | 2023-02-09 | M | A | 17,533 | $0.00 | 170,559 | D | — | — | (F1) Includes 2,745 shares acquired on January 31, 2023 pursuant to EyePoint's 2019 Employee Stock Purchase Plan. |
| 3 | Derivative | Restricted Stock Units | 2023-02-09 | M | D | 20,000 | $0.00 | 40,000 | D | $0.00 · — to — | 20,000 Common Stock | (F2) The restricted stock units vest in three annual installments beginning February 9, 2023. |
| 4 | Derivative | Restricted Stock Units | 2023-02-09 | M | D | 17,533 | $0.00 | 17,534 | D | $0.00 · — to — | 17,533 Common Stock | (F3) The restricted stock units vest in three ratable annual installments beginning February 9, 2022. |